Logo image of ALBIO.PA

BIOSYNEX (ALBIO.PA) Stock Overview

EPA:ALBIO - FR0011005933 - Common Stock

1.19 EUR
+0.02 (+1.71%)
Last: 9/4/2025, 7:00:00 PM

ALBIO.PA Key Statistics, Chart & Performance

Key Statistics
52 Week High4.68
52 Week Low1.05
Market Cap22.31M
Shares18.75M
Float7.77M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-3.37
PEN/A
Fwd PE2.51
Earnings (Next)N/A N/A
IPO03-21 2011-03-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


ALBIO.PA short term performance overview.The bars show the price performance of ALBIO.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20 -25

ALBIO.PA long term performance overview.The bars show the price performance of ALBIO.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ALBIO.PA is 1.19 EUR. In the past month the price decreased by -2.46%. In the past year, price decreased by -73.26%.

BIOSYNEX / ALBIO Daily stock chart

ALBIO.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 27.34 199.84B
IUI1.DE INTUITIVE SURGICAL INC 56.27 139.39B
BSX.DE BOSTON SCIENTIFIC CORP 38.19 137.51B
1BSX.MI BOSTON SCIENTIFIC CORP 37.12 133.45B
2M6.DE MEDTRONIC PLC 16.87 102.79B
1SHL.MI SIEMENS HEALTHINEERS AG 19.87 53.35B
SHL.DE SIEMENS HEALTHINEERS AG 19.81 53.17B
BOX.DE BECTON DICKINSON AND CO 13.29 46.68B
EWL.DE EDWARDS LIFESCIENCES CORP 31.57 40.97B
DC4.DE DEXCOM INC 43.73 25.04B
PHIA.AS KONINKLIJKE PHILIPS NV 16.51 22.90B
PHI1.DE KONINKLIJKE PHILIPS NV 16.49 22.87B

About ALBIO.PA

Company Profile

ALBIO logo image Biosynex SA engages in the provision of development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. The company is headquartered in Illkirch-Graffenstaden, Grand Est and currently employs 486 full-time employees. The company went IPO on 2011-03-21. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). The company operates through Fumouze Diagnostics and SR2B.

Company Info

BIOSYNEX

22 Boulevard Sebastien Brant

Illkirch-Graffenstaden GRAND EST FR

Employees: 515

ALBIO Company Website

ALBIO Investor Relations

Phone: 33388787887

BIOSYNEX / ALBIO.PA FAQ

What is the stock price of BIOSYNEX today?

The current stock price of ALBIO.PA is 1.19 EUR. The price increased by 1.71% in the last trading session.


What is the ticker symbol for BIOSYNEX stock?

The exchange symbol of BIOSYNEX is ALBIO and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALBIO.PA stock listed?

ALBIO.PA stock is listed on the Euronext Paris - Matif exchange.


What is BIOSYNEX worth?

BIOSYNEX (ALBIO.PA) has a market capitalization of 22.31M EUR. This makes ALBIO.PA a Nano Cap stock.


How many employees does BIOSYNEX have?

BIOSYNEX (ALBIO.PA) currently has 515 employees.


What are the support and resistance levels for BIOSYNEX (ALBIO.PA) stock?

BIOSYNEX (ALBIO.PA) has a support level at 1.19 and a resistance level at 1.19. Check the full technical report for a detailed analysis of ALBIO.PA support and resistance levels.


Is BIOSYNEX (ALBIO.PA) expected to grow?

The Revenue of BIOSYNEX (ALBIO.PA) is expected to grow by 15.05% in the next year. Check the estimates tab for more information on the ALBIO.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOSYNEX (ALBIO.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOSYNEX (ALBIO.PA) stock pay dividends?

ALBIO.PA does not pay a dividend.


What is the Price/Earnings (PE) ratio of BIOSYNEX (ALBIO.PA)?

BIOSYNEX (ALBIO.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.37).


ALBIO.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ALBIO.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ALBIO.PA. ALBIO.PA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALBIO.PA Financial Highlights

Over the last trailing twelve months ALBIO.PA reported a non-GAAP Earnings per Share(EPS) of -3.37. The EPS decreased by -12.27% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -22.24%
ROE -53.75%
Debt/Equity 0.19
Chartmill High Growth Momentum
EPS Q2Q%-22.69%
Sales Q2Q%-5.76%
EPS 1Y (TTM)-12.27%
Revenue 1Y (TTM)8.76%

ALBIO.PA Forecast & Estimates

For the next year, analysts expect an EPS growth of 475% and a revenue growth 15.05% for ALBIO.PA


Analysts
Analysts86.67
Price TargetN/A
EPS Next Y475%
Revenue Next Year15.05%

ALBIO.PA Ownership

Ownership
Inst Owners0.46%
Ins Owners5.7%
Short Float %N/A
Short RatioN/A